|
⚲
|
| Keyboard |
| Astrazeneca AB
✚
|
|
|---|---|
| CIK # | 0000928966 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000928966] | |
| 4 | [0000928966] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Astrazeneca PLC | |
| Astrazeneca AB | |
| Entasis Therapeutics Holdings Inc | |
| Albireo Pharma Inc | |
| Regulus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Conversion | 1,918,185 | ||
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2018-09-28 | Buy | 246,666 | $15.00 | 3,699,990 |
|
Entasis Therapeutics Holdings Inc ETTX
Series A Preferred Stock · derivative
|
2018-09-28 | Conversion | 33,499,900 | $0.00 | |
|
Albireo Pharma Inc ALBO
Common Stock, $0.01 par value per share
|
2017-12-01 | Sell | 500,000 | $21.40 | 10,700,000 |
|
Regulus Therapeutics Inc RGLS
COMMON STOCK
|
2014-11-12 | Sell | 2,000,000 | $17.00 | 34,000,000 |